CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | Smith Michael Alexander Chief Legal Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,248 | 14,282 | ||
| 2026-02-23 | Brennan David R Director | Gift | −6,000 | 60,933 | ||
| 2026-02-19 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 307,444 |
| 2026-02-19 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 311,884 |
| 2026-02-19 | Lewis William Chair and CEO | Sale 10b5-1 | −1,988 | $149.17 | $297K | 309,896 |
| 2026-02-19 | Lewis William Chair and CEO | Sale 10b5-1 | −1,891 | $150.10 | $284K | 308,005 |
| 2026-02-19 | Lewis William Chair and CEO | Sale 10b5-1 | −3,413 | $151.12 | $516K | 304,592 |
| 2026-02-19 | Lewis William Chair and CEO | Sale 10b5-1 | −2,377 | $151.92 | $361K | 302,215 |
| 2026-02-19 | Lewis William Chair and CEO | Sale 10b5-1 | −1,030 | $153.38 | $158K | 301,185 |
| 2026-02-19 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 62,591 | ||
| 2026-02-19 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 44,400 | ||
| 2026-02-09 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 308,322 |
| 2026-02-09 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 314,581 |
| 2026-02-09 | Lewis William Chair and CEO | Sale 10b5-1 | −4,888 | $147.17 | $719K | 309,693 |
| 2026-02-09 | Lewis William Chair and CEO | Sale 10b5-1 | −7,221 | $148.02 | $1.1M | 302,472 |
| 2026-02-09 | Lewis William Chair and CEO | Sale 10b5-1 | −1,287 | $148.83 | $192K | 301,185 |
| 2026-02-09 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 48,840 | ||
| 2026-02-09 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 68,850 | ||
| 2026-02-09 | MCGIRR DAVID W J Director | Gift | −53,400 | 44,323 | ||
| 2026-02-09 | MCGIRR DAVID W J Director | Gift | +53,400 | 53,400 |
Page 8 of 23 · 448 trades